Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

NCT00111956 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Metabolic Syndrome X

Interventions

DRUG: Etanercept
DRUG: Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]